TRPV1 may increase the effectiveness of estrogen therapy on neuroprotection and neuroregeneration

Aging induces physical deterioration, loss of the blood brain barrier, neuronal loss-induced mental and neurodegenerative diseases. Hypotalamus-hypophysis-gonad axis aging precedes symptoms of menopause or andropause and is a major determinant of sensory and cognitive integrated function. Sexual ste...

Full description

Bibliographic Details
Main Authors: Ricardo Ramírez-Barrantes, Ivanny Marchant, Pablo Olivero
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:Neural Regeneration Research
Subjects:
Online Access:http://www.nrronline.org/article.asp?issn=1673-5374;year=2016;volume=11;issue=8;spage=1204;epage=1207;aulast=Ramírez-Barrantes
id doaj-19e584764fe4493da91f7365299c7b1d
record_format Article
spelling doaj-19e584764fe4493da91f7365299c7b1d2020-11-25T03:50:16ZengWolters Kluwer Medknow PublicationsNeural Regeneration Research1673-53742016-01-011181204120710.4103/1673-5374.189162TRPV1 may increase the effectiveness of estrogen therapy on neuroprotection and neuroregenerationRicardo Ramírez-BarrantesIvanny MarchantPablo OliveroAging induces physical deterioration, loss of the blood brain barrier, neuronal loss-induced mental and neurodegenerative diseases. Hypotalamus-hypophysis-gonad axis aging precedes symptoms of menopause or andropause and is a major determinant of sensory and cognitive integrated function. Sexual steroids support important functions, exert pleiotropic effects in different sensory cells, promote regeneration, plasticity and health of the nervous system. Their diminution is associated with impaired cognitive and mental health and increased risk of neurodegenerative diseases. Then, restoring neuroendocrine axes during aging can be key to enhance brain health through neuroprotection and neuroregeneration, depending on the modulation of plasticity mechanisms. Estrogen-dependent transient receptor potential cation channel, subfamily V, member 1 (TRPV1) expression induces neuroprotection, neurogenesis and regeneration on damaged tissues. Agonists of TRPV1 can modulate neuroprotection and repair of sensitive neurons, while modulators as other cognitive enhancers may improve the survival rate, differentiation and integration of neural stem cell progenitors in functional neural network. Menopause constitutes a relevant clinical model of steroidal production decline associated with progressive cognitive and mental impairment, which allows exploring the effects of hormone therapy in health outcomes such as dysfunction of CNS. Simulating the administration of hormone therapy to virtual menopausal individuals allows assessing its hypothetical impact and sensitivity to conditions that modify the effectiveness and efficiency.http://www.nrronline.org/article.asp?issn=1673-5374;year=2016;volume=11;issue=8;spage=1204;epage=1207;aulast=Ramírez-BarrantesTRPV1; estrogen; hormonal replacent; neuroprotection; aging
collection DOAJ
language English
format Article
sources DOAJ
author Ricardo Ramírez-Barrantes
Ivanny Marchant
Pablo Olivero
spellingShingle Ricardo Ramírez-Barrantes
Ivanny Marchant
Pablo Olivero
TRPV1 may increase the effectiveness of estrogen therapy on neuroprotection and neuroregeneration
Neural Regeneration Research
TRPV1; estrogen; hormonal replacent; neuroprotection; aging
author_facet Ricardo Ramírez-Barrantes
Ivanny Marchant
Pablo Olivero
author_sort Ricardo Ramírez-Barrantes
title TRPV1 may increase the effectiveness of estrogen therapy on neuroprotection and neuroregeneration
title_short TRPV1 may increase the effectiveness of estrogen therapy on neuroprotection and neuroregeneration
title_full TRPV1 may increase the effectiveness of estrogen therapy on neuroprotection and neuroregeneration
title_fullStr TRPV1 may increase the effectiveness of estrogen therapy on neuroprotection and neuroregeneration
title_full_unstemmed TRPV1 may increase the effectiveness of estrogen therapy on neuroprotection and neuroregeneration
title_sort trpv1 may increase the effectiveness of estrogen therapy on neuroprotection and neuroregeneration
publisher Wolters Kluwer Medknow Publications
series Neural Regeneration Research
issn 1673-5374
publishDate 2016-01-01
description Aging induces physical deterioration, loss of the blood brain barrier, neuronal loss-induced mental and neurodegenerative diseases. Hypotalamus-hypophysis-gonad axis aging precedes symptoms of menopause or andropause and is a major determinant of sensory and cognitive integrated function. Sexual steroids support important functions, exert pleiotropic effects in different sensory cells, promote regeneration, plasticity and health of the nervous system. Their diminution is associated with impaired cognitive and mental health and increased risk of neurodegenerative diseases. Then, restoring neuroendocrine axes during aging can be key to enhance brain health through neuroprotection and neuroregeneration, depending on the modulation of plasticity mechanisms. Estrogen-dependent transient receptor potential cation channel, subfamily V, member 1 (TRPV1) expression induces neuroprotection, neurogenesis and regeneration on damaged tissues. Agonists of TRPV1 can modulate neuroprotection and repair of sensitive neurons, while modulators as other cognitive enhancers may improve the survival rate, differentiation and integration of neural stem cell progenitors in functional neural network. Menopause constitutes a relevant clinical model of steroidal production decline associated with progressive cognitive and mental impairment, which allows exploring the effects of hormone therapy in health outcomes such as dysfunction of CNS. Simulating the administration of hormone therapy to virtual menopausal individuals allows assessing its hypothetical impact and sensitivity to conditions that modify the effectiveness and efficiency.
topic TRPV1; estrogen; hormonal replacent; neuroprotection; aging
url http://www.nrronline.org/article.asp?issn=1673-5374;year=2016;volume=11;issue=8;spage=1204;epage=1207;aulast=Ramírez-Barrantes
work_keys_str_mv AT ricardoramirezbarrantes trpv1mayincreasetheeffectivenessofestrogentherapyonneuroprotectionandneuroregeneration
AT ivannymarchant trpv1mayincreasetheeffectivenessofestrogentherapyonneuroprotectionandneuroregeneration
AT pabloolivero trpv1mayincreasetheeffectivenessofestrogentherapyonneuroprotectionandneuroregeneration
_version_ 1724491310791917568